NDC 71334-235 – Aqvesme

Mitapivat 100 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC71334-235

Product details

Brand name
Aqvesme
Generic name
Mitapivat
Labeler
Agios Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA216196
Marketed since
December 23, 2025
Listing expires
December 31, 2027
Pharmacologic class
Pyruvate Kinase Activator

Active ingredients

Uses, dosage, side effects and warnings for Aqvesme →

Package NDC codes (1)

Package NDCDescriptionSince
71334-235-004 BLISTER PACK in 1 CARTON (71334-235-00) / 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-235-14)Dec 23, 2025